Necrotic enteritis is a severe, economically devastating intestinal disease primarily affecting commercial poultry, particularly broiler chickens and turkeys raised in intensive production systems. The condition is caused by toxins produced by Clostridium perfringens, a spore-forming anaerobic bacterium that normally exists in low numbers within the intestinal tract of healthy birds but can proliferate rapidly under certain conditions to cause acute disease. Necrotic enteritis represents one of the most significant health challenges facing the global poultry industry, with annual economic losses estimated in the billions of dollars when accounting for mortality, reduced performance, treatment costs, and prevention program expenditures. The disease has gained additional importance following the reduction or elimination of antibiotic growth promoters in many countries, as these feed additives previously provided incidental control of clostridial populations.
The prevalence of necrotic enteritis varies considerably across different production systems, geographic regions, and management practices, though virtually all commercial poultry operations face some degree of risk from this condition. Studies indicate that clinical necrotic enteritis occurs in approximately two to four percent of broiler flocks in most production systems, but subclinical disease affecting growth rates and feed conversion without obvious mortality may be far more common. The transition away from prophylactic antimicrobial use in poultry production has coincided with increased necrotic enteritis incidence in many regions, prompting intensive research into alternative prevention strategies. Turkey production similarly experiences significant necrotic enteritis challenges, with young poults particularly susceptible during critical early growth phases.
The economic and welfare impact of necrotic enteritis extends far beyond direct mortality losses, which themselves can reach twenty-five to fifty percent in severe acute outbreaks. Subclinical necrotic enteritis impairs feed conversion efficiency and growth rates without producing obvious clinical signs, potentially affecting a large proportion of birds in infected flocks. Intestinal damage reduces nutrient absorption, meaning affected birds require more feed to achieve target weights, significantly increasing production costs. Welfare concerns arise from the obvious distress experienced by clinically affected birds, the rapid onset of severe illness, and the challenges of identifying and treating affected individuals within large commercial flocks. Condemnations at processing due to liver lesions associated with necrotic enteritis represent additional economic losses that may not be anticipated based on farm-level observations.
Understanding necrotic enteritis is essential for all poultry producers because the condition requires proactive management rather than reactive treatment to achieve effective control. The multifactorial nature of necrotic enteritis means that no single intervention provides complete protection, and successful prevention requires integration of nutrition, housing, health management, and biosecurity measures. Early recognition of predisposing conditions and prodromal signs enables implementation of control measures before major losses occur. The economic stakes involved in necrotic enteritis control justify substantial investment in prevention programs, diagnostic monitoring, and research into emerging management tools and strategies.
